Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies

Abstract : Resistance to chemotherapies, particularly to anticancer treatments, is an increasing medical concern. Among the many mechanisms at work in cancers, one of the most important is the selection of tumor cells expressing resistance genes or phenotypes. Motivated by the theory of mutation-selection in adaptive evolution, we propose a model based on a continuous variable that represents the expression level of a resistance gene (or genes, yielding a phenotype) influencing in healthy and tumor cells birth/death rates, effects of chemotherapies (both cytotoxic and cytostatic) and mutations. We extend previous work by demonstrating how qualitatively different actions of chemotherapeutic and cytostatic treatments may induce different levels of resistance. The mathematical interest of our study is in the formalism of constrained Hamilton-Jacobi equations in the framework of viscosity solutions. We derive the long-term temporal dynamics of the fittest traits in the regime of small mutations. In the context of adaptive cancer management, we also analyse whether an optimal drug level is better than the maximal tolerated dose.
Document type :
Journal articles
ESAIM: Mathematical Modelling and Numerical Analysis, EDP Sciences, 2013, pp.23. <10.1051/m2an/2012031>


https://hal.archives-ouvertes.fr/hal-00714274
Contributor : Alexander Lorz <>
Submitted on : Tuesday, July 3, 2012 - 6:07:00 PM
Last modification on : Thursday, October 30, 2014 - 1:09:42 PM

Files

ATMJB_11.pdf
fileSource_public_author

Identifiers

Collections

Citation

Alexander Lorz, Tommaso Lorenzi, Michael E. Hochberg, Jean Clairambault, Benoît Perthame. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies. ESAIM: Mathematical Modelling and Numerical Analysis, EDP Sciences, 2013, pp.23. <10.1051/m2an/2012031>. <hal-00714274>

Export

Share

Metrics

Consultation de
la notice

433

Téléchargement du document

168